Levemopamil
Code | Size | Price |
---|
TAR-T25692-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25692-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25692-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Levemopamil is used as a calcium-channel blocker.
CAS:
101238-51-1
Formula:
C23H30N2
Molecular Weight:
334.507
Purity:
0.98
SMILES:
CC(C)[C@](CCCN(C)CCc1ccccc1)(C#N)c1ccccc1
References
1. Fleischer JE, Nakakimura K, Drummond JC, Scheller MS, Zornow MH, Grafe MR, Shapiro HM. Effects of levemopamil on neurologic and histologic outcome after cardiac arrest in cats. Crit Care Med. 1992 Jan;20(1):126-34. PubMed PMID: 1729030.
2. Heim C, Sieklucka M, Sontag KH. Levemopamil injection after cerebral oligemia reduces spatial memory deficits in rats. Pharmacol Biochem Behav. 1994 Jul;48(3):613-9. PubMed PMID: 7938114.
3. Elger B, Seega J, Raschack M. Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging. Eur J Pharmacol. 1994 Mar 11;254(1-2):65-71. PubMed PMID: 8206118.
4. Elger B, Seega J, Brendel R. Magnetic resonance imaging study on the effect of levemopamil on the size of intracerebral hemorrhage in rats. Stroke. 1994 Sep;25(9):1836-41. PubMed PMID: 8073466.